Graziano et al. [23] retrospectively analysed the serum albumin levels of 2425 patients with non-metastatic invasive breast cancer (stages I–III) and reported that lower serum albumin levels served as a prognostic factor for poor survival in patients with early stage breast cancer, regardless of their stage. This evidence concerns the gene ALB and breast carcinoma.